Bio-Rad Laboratories (BIO) News Today → The asset beating inflation by 4x (From Colonial Metals) (Ad) Free bio Stock Alerts $279.83 +0.52 (+0.19%) (As of 05/3/2024 08:52 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineFisher Asset Management LLC Sells 14,338 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - May 5 at 8:13 AMBio-Rad Laboratories (BIO) Set to Announce Quarterly Earnings on Tuesdayamericanbankingnews.com - May 5 at 4:10 AMBio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conferencefinance.yahoo.com - May 1 at 10:14 AMBio-Rad's Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conferencebusinesswire.com - May 1 at 9:00 AMBio-Rad Laboratories (BIO) Scheduled to Post Earnings on Tuesdaymarketbeat.com - April 30 at 10:09 AMAnchor Capital Advisors LLC Sells 20,844 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 29 at 5:26 PMBio-Rad Laboratories (NYSE:BIO) Rating Increased to Buy at StockNews.comamericanbankingnews.com - April 29 at 5:10 AMIFM Investors Pty Ltd Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 28 at 10:42 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - April 28 at 4:10 AMSector Gamma AS Makes New $7.62 Million Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 27 at 4:38 PMBio-Rad Announces Life Science Group Management Changesbusinesswire.com - April 26 at 8:30 AMS&P 500 (SPX) today: Top movers are Bio-Rad Laboratories Inc and Agilent Technologies, Inc.usatoday.com - April 23 at 3:09 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Bought by Duality Advisers LPmarketbeat.com - April 22 at 11:54 AMKornitzer Capital Management Inc. KS Cuts Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 20 at 11:18 AMCommit To Purchase Bio-Rad Laboratories At $185, Earn 1.3% Annualized Using Optionsnasdaq.com - April 19 at 11:28 PMBio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024businesswire.com - April 18 at 9:00 AMBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2025 Earnings of $2.39 Per Share, Zacks Research Forecastsmarketbeat.com - April 17 at 5:55 PMZacks Research Equities Analysts Reduce Earnings Estimates for Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 16 at 7:27 AMLecap Asset Management Ltd. Purchases New Position in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 13 at 8:08 PMRaymond James & Associates Sells 21,649 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 12 at 4:18 AMOncocyte, Bio-Rad Partner on Global Launch of Transplant Assaymarketwatch.com - April 11 at 6:28 PMOncocyte stock rallies 90% post-market on Bio-Rad partnershipseekingalpha.com - April 11 at 6:28 PMBio-Rad Laboratories (NYSE:BIO) Stock Price Down 3.9%marketbeat.com - April 11 at 1:48 PMAllspring Global Investments Holdings LLC Has $53.64 Million Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 11 at 6:58 AMBio-Rad's Chief Operating Officer Andrew Last to Retirebusinesswire.com - April 10 at 4:15 PMBio-Rad Laboratories (NYSE:BIO) Downgraded by StockNews.com to "Hold"marketbeat.com - April 5 at 11:10 PMQ2 2024 Earnings Forecast for Bio-Rad Laboratories, Inc. Issued By Zacks Research (NYSE:BIO)marketbeat.com - April 4 at 8:49 AMGlobal Clinical Microbiology Market Size To Worth USD 6.58 Billion By 2033 | CAGR of 4.49%finance.yahoo.com - April 3 at 7:24 PMBio-Rad Laboratories (NYSE:BIO) Shares Gap Down to $328.72marketbeat.com - April 3 at 2:54 PMStocks Waver on Higher Bond Yields Ahead of Fed Chair Powellmsn.com - April 3 at 1:51 PMCitigroup Lowers Bio-Rad Laboratories (NYSE:BIO) to Neutralmarketbeat.com - April 3 at 8:24 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Given Consensus Rating of "Buy" by Analystsmarketbeat.com - April 3 at 8:23 AMBio-Rad Laboratories, Inc. (NYSE:BIO) to Post Q1 2024 Earnings of $2.09 Per Share, Zacks Research Forecastsmarketbeat.com - April 3 at 6:00 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Fifth Third Bancorpmarketbeat.com - April 3 at 5:18 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Short Interest Up 15.1% in Marchmarketbeat.com - April 2 at 10:55 PMAssenagon Asset Management S.A. Has $4.07 Million Stake in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - April 2 at 4:38 AM25 Countries with Highest Malaria Death Ratesfinance.yahoo.com - March 31 at 4:48 PMGlobal Adult Hemoglobinopathy Testing Market to Reach $513.7 Million by 2030finance.yahoo.com - March 28 at 2:30 PMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Nordea Investment Management ABmarketbeat.com - March 25 at 4:40 AMBio-Rad Laboratories, Inc. (NYSE:BIO) Shares Sold by Vanguard Group Inc.marketbeat.com - March 21 at 4:45 AMBio-Rad Names Roop Lakkaraju Chief Financial Officermarketwatch.com - March 21 at 2:53 AMDeutsche Bank AG Decreases Holdings in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 19 at 4:41 AMThermo Fisher: Hold Rating Justified Amid Modest Growth Prospects and Full Valuationmarkets.businessinsider.com - March 18 at 2:36 PMBIO Apr 2024 340.000 callfinance.yahoo.com - March 17 at 11:34 PMShort Interest in Bio-Rad Laboratories, Inc. (NYSE:BIO) Drops By 14.3%marketbeat.com - March 16 at 11:19 AMComerica Bank Invests $11.05 Million in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 15 at 5:00 AMLaser Capture Microdissection Market Worth $306 million | MarketsandMarketsfinanznachrichten.de - March 14 at 12:30 PMTudor Investment Corp Et Al Makes New Investment in Bio-Rad Laboratories, Inc. (NYSE:BIO)marketbeat.com - March 14 at 4:50 AMGlobal Syndromic Multiplex Panels Market Set for Rapid Expansion, Reveals New 2024-2028 Sector Forecastuk.finance.yahoo.com - March 12 at 1:28 PMGene Expression Analysis Market Worth $6.2 billion | MarketsandMarketsfinanznachrichten.de - March 12 at 1:28 PM Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address The asset beating inflation by 4x (Ad)"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties. That's why we have released our Free Precious Metals Investment Guide that explains all the details BIO Media Mentions By Week BIO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIO News Sentiment▼0.320.41▲Average Medical News Sentiment BIO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIO Articles This Week▼75▲BIO Articles Average Week Get Bio-Rad Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for BIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Waters News Illumina News Bio-Rad Laboratories News Revvity News 10x Genomics News Olink Holding AB (publ) News Avantor News Encompass Health News Penumbra News Ascendis Pharma A/S News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIO) was last updated on 5/6/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyThe asset beating inflation by 4xColonial MetalsCould Your Accounts Be Frozen?Allegiance GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRSVP: Charles Payne’s Cash Flow WorkshopUnstoppable ProsperityIs Tesla going out of business?DTI Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Rad Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
